Pay in 4 interest-free payments of $5.27 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
The cost above covers your medication only
How common is hair loss on retatrutide specifically
18 GLP-1 RAs were initially approved by the FDA for the treatment of type 2 diabetes based on phase 3 trials demonstrating superiority in reducing hemoglobin A 1c and improving cardiovascular outcomes compared with other antihyperglycemic medications
This option allows patients to evaluate tolerance and effectiveness before potentially advancing to higher-dose formulations
Update the Hims Supply Tracker and well keep the FDA informed on current access
US$ 20.78
US$ 26.45
US$ 26.68
US$ 20.50
US$ 26.99
US$ 27.82
US$ 22.74
US$ 23.91
US$ 24.63
